|

The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction

RECRUITINGSponsored by Universitas Diponegoro
Actively Recruiting
SponsorUniversitas Diponegoro
Started2024-01-01
Est. completion2024-06-30
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06586424

Summary

This study aims to evaluate the prognostic value of the anion gap in predicting major adverse cardiovascular events among patients with ST-segment elevation myocardial infarction. Researchers will collect information based on hospital registry as secondary data of in patient who had diagnosed as ST-segment elevation myocardial infarction and underwent primary percutaneous coronary intervention. The data consist of demographic data, clinical presentation, laboratory, and angiography result were collected from hospital registry by reviewing medical record. Then, the data was analyzed by using IBM SPSS Statistics v26.

Eligibility

Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

* Adults with 18 - 70 years old with diagnosis of STEMI who underwent PPCI

Exclusion Criteria:

* History of heart failure due to any causes
* Cardiogenic shock before PPCI
* Any infection at the time of presentation
* Pregnant woman
* Other causes of high anion gap levels such as chronic kidney disease, metabolic acidosis, etc

Conditions2

Heart DiseaseST-segment Elevation Myocardial Infarction (STEMI)

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.